CN106147753B - Thiazole orange styrene compound as G-quadruplex nucleic acid fluorescent probe - Google Patents
Thiazole orange styrene compound as G-quadruplex nucleic acid fluorescent probe Download PDFInfo
- Publication number
- CN106147753B CN106147753B CN201510213543.6A CN201510213543A CN106147753B CN 106147753 B CN106147753 B CN 106147753B CN 201510213543 A CN201510213543 A CN 201510213543A CN 106147753 B CN106147753 B CN 106147753B
- Authority
- CN
- China
- Prior art keywords
- quadruplex
- nucleic acid
- probe
- fluorescent probe
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108091081406 G-quadruplex Proteins 0.000 title claims abstract description 39
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 13
- -1 Thiazole orange styrene compound Chemical class 0.000 title description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 title 1
- 239000000523 sample Substances 0.000 claims abstract description 31
- 238000001514 detection method Methods 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000011543 agarose gel Substances 0.000 claims abstract 2
- 239000000499 gel Substances 0.000 claims abstract 2
- 229920002401 polyacrylamide Polymers 0.000 claims abstract 2
- 150000001875 compounds Chemical class 0.000 claims description 15
- DXYYSGDWQCSKKO-UHFFFAOYSA-N 2-methylbenzothiazole Chemical compound C1=CC=C2SC(C)=NC2=C1 DXYYSGDWQCSKKO-UHFFFAOYSA-N 0.000 claims description 6
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 claims description 4
- GSSXPRLZETYVIP-UHFFFAOYSA-N 4,4-bis(methylamino)cyclohexa-1,5-diene-1-carbaldehyde Chemical compound CNC1(NC)CC=C(C=O)C=C1 GSSXPRLZETYVIP-UHFFFAOYSA-N 0.000 claims description 2
- HQAIROMRVBVWSK-UHFFFAOYSA-N 4-chloro-2-methylquinoline Chemical compound C1=CC=CC2=NC(C)=CC(Cl)=C21 HQAIROMRVBVWSK-UHFFFAOYSA-N 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 18
- 102000039446 nucleic acids Human genes 0.000 abstract description 18
- 108020004707 nucleic acids Proteins 0.000 abstract description 18
- 150000007523 nucleic acids Chemical class 0.000 abstract description 17
- 206010034972 Photosensitivity reaction Diseases 0.000 abstract description 2
- 210000000170 cell membrane Anatomy 0.000 abstract description 2
- 230000035699 permeability Effects 0.000 abstract description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 abstract description 2
- 231100000018 phototoxicity Toxicity 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 14
- 102000053602 DNA Human genes 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000002189 fluorescence spectrum Methods 0.000 description 7
- ACOJCCLIDPZYJC-UHFFFAOYSA-M thiazole orange Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1=CC=C2C(C=C3N(C4=CC=CC=C4S3)C)=CC=[N+](C)C2=C1 ACOJCCLIDPZYJC-UHFFFAOYSA-M 0.000 description 7
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
- 239000000975 dye Substances 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 238000001308 synthesis method Methods 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 3
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 229920002477 rna polymer Polymers 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 125000003011 styrenyl group Chemical class [H]\C(*)=C(/[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KAFZOLYKKCWUBI-HPMAGDRPSA-N (2s)-2-[[(2s)-2-[[(2s)-1-[(2s)-3-amino-2-[[(2s)-2-[[(2s)-2-(3-cyclohexylpropanoylamino)-4-methylpentanoyl]amino]-5-methylhexanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]butanediamide Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CCC(C)C)C(=O)N[C@@H](CN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O)C(=O)CCC1CCCCC1 KAFZOLYKKCWUBI-HPMAGDRPSA-N 0.000 description 1
- FOLCUFKJHSQMEL-BIXPGCQOSA-N (4-butylcyclohexyl) N-[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamate Chemical compound CCCCC1CCC(CC1)OC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]2CCNC2=O)C=O FOLCUFKJHSQMEL-BIXPGCQOSA-N 0.000 description 1
- UXKLQDCALAWFIU-VKNDCNMPSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-4,7-dihydroxy-6-tetradecoxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCCCC)C1=CC=CC=C1 UXKLQDCALAWFIU-VKNDCNMPSA-N 0.000 description 1
- VGNCBRNRHXEODV-XXVHXNRLSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-6-dodecoxy-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCC)C1=CC=CC=C1 VGNCBRNRHXEODV-XXVHXNRLSA-N 0.000 description 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- UZOFELREXGAFOI-UHFFFAOYSA-N 4-methylpiperidine Chemical compound CC1CCNCC1 UZOFELREXGAFOI-UHFFFAOYSA-N 0.000 description 1
- 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 101710135898 Myc proto-oncogene protein Proteins 0.000 description 1
- 102100038895 Myc proto-oncogene protein Human genes 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000016971 Proto-Oncogene Proteins c-kit Human genes 0.000 description 1
- 108010014608 Proto-Oncogene Proteins c-kit Proteins 0.000 description 1
- 102000009096 Proto-Oncogene Proteins c-myb Human genes 0.000 description 1
- 108010087776 Proto-Oncogene Proteins c-myb Proteins 0.000 description 1
- 101710150448 Transcriptional regulator Myc Proteins 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 150000003934 aromatic aldehydes Chemical class 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- QMYWABFEOZMOIL-UHFFFAOYSA-N heptanediamide Chemical compound NC(=O)CCCCCC(N)=O QMYWABFEOZMOIL-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000005445 isotope effect Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种荧光探针及其制备方法,以及其在水溶液中、凝胶中和细胞中检测核酸G-四链体二级结构的用途。The present invention relates to a fluorescent probe and its preparation method, as well as its use in detecting the secondary structure of nucleic acid G-quadruplex in aqueous solution, gel and cell.
背景技术Background technique
核酸不但是一切生物细胞的基本成分,还对生物体的生长、发育、繁殖、遗传及变异等重大生命现象起主宰作用。核酸大分子分为两类:脱氧核糖核酸(DNA)和核糖核酸(RNA),在蛋白质的复制和合成中起着储存和传递遗传信息的作用。Nucleic acids are not only the basic components of all biological cells, but also play a dominant role in major life phenomena such as growth, development, reproduction, inheritance and variation of organisms. Nucleic acid macromolecules are divided into two categories: deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), which play the role of storing and transmitting genetic information in the replication and synthesis of proteins.
G-四链体(G-quadruplex)是一种特殊的核酸二级结构。人类基因组中很多富鸟嘌呤区域具有形成这一结构的能力,包括端粒末端鸟嘌呤重复序列,以及多种基因的启动子区域,如c-kit、c-myc、c-myb、bcl-2、PDGF、kRAS、VEGF、Rb和胰岛素基因等。G-四链体结构具有多态性,链的数量和取向、loop的连接方式以及鸟嘌呤的糖苷扭转角以及与羰基负电中心配位的金属离子等多方面决定了G-四链体的类型和构象,这些差异性也为蛋白和小分子化合物提供了多个识别位点。根据链的取向不同,G-四链体分为正平行,反平行与混合型三种构象。G-quadruplex (G-quadruplex) is a special nucleic acid secondary structure. Many guanine-rich regions in the human genome have the ability to form this structure, including telomeric terminal guanine repeats, and the promoter regions of various genes, such as c-kit, c-myc, c-myb, bcl-2 , PDGF, kRAS, VEGF, Rb and insulin genes. The G-quadruplex structure is polymorphic. The number and orientation of the chains, the connection method of loops, the glycoside torsion angle of guanine, and the metal ions coordinated to the negatively charged center of the carbonyl group determine the type of G-quadruplex. and conformation, these differences also provide multiple recognition sites for proteins and small-molecule compounds. Depending on the orientation of the chains, G-quadruplexes are divided into three conformations: normal parallel, antiparallel and mixed.
G-四链体结构的形成对于体内的一系列生理过程都存在调控作用。研究证明,某些启动子区域的G-四链体结构会显著影响基因的转录和翻译水平,因此G-四链体结构被认为是起到分子开关的功能,其形成和拆散可能涉及到信号传导、细胞凋亡和细胞增殖等一系列体内重要的生理过程。所以,在体内或者体外试验中,能够特异性地检测出G-四链体结构的存在或者形成,对于研究G-四链体结构的相关生物学功能以及开发以G-四链体结构为靶点的抗癌药物等方面都具有非常重要的作用。The formation of G-quadruplex structure has a regulatory effect on a series of physiological processes in vivo. Studies have shown that the G-quadruplex structure in some promoter regions can significantly affect the transcription and translation levels of genes, so the G-quadruplex structure is considered to function as a molecular switch, and its formation and disassembly may involve signaling A series of important physiological processes in vivo, such as conduction, apoptosis and cell proliferation. Therefore, in vivo or in vitro experiments, the existence or formation of the G-quadruplex structure can be specifically detected, which is useful for studying the related biological functions of the G-quadruplex structure and developing the G-quadruplex structure as the target. Anticancer drugs and other aspects of the point have a very important role.
随着生物技术的发展,对于核酸标记的要求越来越高,以往通过同位素效应来进行DNA分子测序的方法已经无法满足需求,而荧光标记作为一种具有检测速度快、重复性好、用样量少、无辐射等优点的标记技术受到广泛重视,并取得迅速发展。已经发现的染色剂有卟啉类、菁类、苯乙烯类等。而其中的噻唑橙(TO)是一种经典的非选择性菁类核酸荧光探针。除了与其他核酸结合后产生荧光外,TO同样可以结合在G-四链体上,产生强烈的荧光。但是,TO不能从其他形式的核酸分子中有效地识别G-四链体二级结构,因而选择性较差限制了TO的应用。为了改良TO的选择性,我们在TO的结构上引入了苯乙烯基团,得到了一类结构新颖的,且对核酸G-四链体结构专一性强的的荧光探针。With the development of biotechnology, the requirements for nucleic acid labeling are getting higher and higher, and the previous method of DNA molecular sequencing by isotope effect has been unable to meet the demand. The labeling technology with the advantages of less amount and no radiation has been widely valued and has developed rapidly. The dyes that have been found are porphyrins, cyanines, styrenes and the like. Among them, thiazole orange (TO) is a classical non-selective cyanine nucleic acid fluorescent probe. In addition to generating fluorescence after binding to other nucleic acids, TO can also bind to G-quadruplex to generate strong fluorescence. However, TO cannot efficiently recognize G-quadruplex secondary structure from other forms of nucleic acid molecules, thus the poor selectivity limits the application of TO. In order to improve the selectivity of TO, we introduced a styrene group into the structure of TO, and obtained a kind of fluorescent probe with novel structure and strong specificity for nucleic acid G-quadruplex structure.
发明内容SUMMARY OF THE INVENTION
本发明的目的在于针对现有技术的不足,提供一种荧光探针。The purpose of the present invention is to provide a fluorescent probe aiming at the deficiencies of the prior art.
本发明的另一个目的在于提供上述探针的制备方法。Another object of the present invention is to provide a method for preparing the above probe.
本发明的再一个目的在于提供上述探针在检测水溶液中、凝胶中和细胞中G-四链体结构的应用。Another object of the present invention is to provide the application of the above probe in detecting G-quadruplex structure in aqueous solution, gel and cell.
本发明通过以下技术方案实现上述目的:The present invention realizes above-mentioned purpose through following technical scheme:
本发明提供了一种荧光探针,其结构式为下式I所示:The present invention provides a fluorescent probe whose structural formula is shown in the following formula I:
式中R1选自或 wherein R 1 is selected from or
R2、R3、R4、R5、R6、R7分别选自H、F、Cl、Br、OH、OCH3、N(CH3)2、C1-6的烷基或C3-6的环烷基;R 2 , R 3 , R 4 , R 5 , R 6 , R 7 are respectively selected from H, F, Cl, Br, OH, OCH 3 , N(CH 3 ) 2 , C 1-6 alkyl or C 3 -6 cycloalkyl;
X为C或N。X is C or N.
本发明同时提供了上述探针的制备方法,表示如下:The present invention also provides the preparation method of the above probe, which is expressed as follows:
具体步骤为:The specific steps are:
将4-氯-2-甲基喹啉与碘甲烷反应,得到化合物将2-甲基苯并噻唑与碘甲烷反应,得到然后将和反应,得到最后将和不同取代基的芳香醛反应,得到最终探针化合物 4-Chloro-2-methylquinoline is reacted with iodomethane to give the compound 2-methylbenzothiazole is reacted with iodomethane to give followed by and react, get will finally React with aromatic aldehydes of different substituents to obtain the final probe compound
本发明还提供了上述探针在检测水溶液中、凝胶中和细胞中G-四链体结构的应用。The present invention also provides the application of the above probe in detecting G-quadruplex structure in aqueous solution, gel and cell.
本发明提供的探针由于具有较大的电子共轭体系和平面,探针分子内的电荷转移效应的强弱可以影响分子的荧光发射强度。当与G-四链体结构发生特异性的作用后,分子内的可转动的双键的柔性受到限制,使分子内电荷转移效应增强,荧光也有明显增强。同时,该类探针的分子结构的柔性的共轭平面,具有可以转动的键,使其可以比较容易堆积在G四分体的平面上,进而与G-四链体具有较强的作用力,同时与其他二级结构的核酸作用较弱。所以,将该探针与不同二级结构的核酸混合时,如果该核酸是G-四链体结构时,其与探针分子间的特异性作用,产生荧光光谱的改变。当核酸的二级结构为其他结构时,则不会产生明显的信号变化。Since the probe provided by the present invention has a large electron conjugated system and plane, the intensity of the charge transfer effect in the probe molecule can affect the fluorescence emission intensity of the molecule. After the specific interaction with the G-quadruplex structure, the flexibility of the rotatable double bond in the molecule is limited, so that the intramolecular charge transfer effect is enhanced, and the fluorescence is also significantly enhanced. At the same time, the flexible conjugated plane of the molecular structure of this type of probe has a rotatable bond, so that it can be easily stacked on the plane of the G-quadruplex, and then has a strong interaction with the G-quadruplex. , and weakly interacts with nucleic acids of other secondary structures. Therefore, when the probe is mixed with nucleic acids with different secondary structures, if the nucleic acid has a G-quadruplex structure, the specific interaction between the probe and the probe molecule will result in a change in the fluorescence spectrum. When the secondary structure of the nucleic acid is other structures, there will be no obvious signal changes.
与现有技术相比,本发明具有以下优点:Compared with the prior art, the present invention has the following advantages:
(1)该类探针制备简单,易得,并且结构稳定,便于储存。(1) This kind of probe is simple to prepare, easy to obtain, and has a stable structure, which is convenient for storage.
(2)本发明提供的探针具有较低的生物毒性、光毒性和光漂白性,且光稳定性佳。(2) The probe provided by the present invention has lower biological toxicity, phototoxicity and photobleaching, and has good photostability.
(3)本发明提供的探针具有良好的水溶性和良好的细胞膜通透性。(3) The probe provided by the present invention has good water solubility and good cell membrane permeability.
(4)本发明提供的探针的光谱范围与生物样品的光谱范围有足够大的差异,在非G-四链体存在的溶液及细胞内具有较低的荧光背景。(4) The spectral range of the probe provided by the present invention is sufficiently different from the spectral range of the biological sample, and has a lower fluorescence background in solutions and cells where non-G-quadruplexes exist.
(5)本发明提供的探针可以特异性地检测识别G-四链体结构,实现了G-四链体结构与其他二级结构的区分,用简单的荧光光谱仪,甚至只需普通紫外灯照射下,肉眼观察就可以识别出核酸样品的二级结构,快捷,操作简便,成本低廉,并且可以实现实地检测。(5) The probe provided by the present invention can specifically detect and recognize the G-quadruplex structure, realize the distinction between the G-quadruplex structure and other secondary structures, and use a simple fluorescence spectrometer, or even an ordinary ultraviolet lamp. Under irradiation, the secondary structure of the nucleic acid sample can be identified by naked eye observation, which is fast, easy to operate, low cost, and can realize on-site detection.
附图说明Description of drawings
图1为为探针6a与AT、DA21、LQ1、Oxy28、random、RNA六种核酸在1∶1浓度下的荧光谱。Figure 1 shows the fluorescence spectra of probe 6a and six nucleic acids AT, DA21, LQ1, Oxy28, random and RNA at 1:1 concentration.
图2为探针6a滴定四链DNA(Oxy28)的荧光光谱。Figure 2 shows the fluorescence spectrum of probe 6a titrated with four-stranded DNA (Oxy28).
图3为探针6a滴定四链DNA(Oxy28)的荧光光谱中C与(F-F0)/F0拟合的曲线.Figure 3 shows the curve fitting of C and (FF 0 )/F 0 in the fluorescence spectrum of probe 6a titrating four-stranded DNA (Oxy28).
图4为探针6a与双链DNA(ds26)和G-四链体(Oxy28)的聚丙酰胺凝胶电泳图Figure 4 shows the polyacrylamide gel electrophoresis of probe 6a with double-stranded DNA (ds26) and G-quadruplex (Oxy28).
图5为染料DAPI染PC3细胞的细胞成像图.Figure 5 is a cell imaging image of PC3 cells stained with the dye DAPI.
图6为探针6a染PC3细胞的细胞成像图.Figure 6 is a cell imaging image of PC3 cells stained with probe 6a.
图7为探针6a与染料DAPI复染PC3细胞的细胞成像图.Figure 7 is a cell imaging image of PC3 cells counterstained with probe 6a and the dye DAPI.
具体实施方式Detailed ways
以下通过具体的实施例进一步说明本发明的技术方案。通过荧光光谱实验证明,本发明涉及的化合物6a由于具有较大的电子共轭体系和平面,与G-四链体结构发生特异性的堆积作用后,荧光光谱发生明显变化,荧光强度增加百倍,甚至只需普通紫外灯照射下,肉眼观察,同时与其他二级结构的核酸作用较弱,没有明显的荧光信号响应,使该类探针具有很好的特异性识别作用。所以,我们将该探针与不同二级结构的DNA混合时,当该DNA为G-四链体结构时,其与探针分子间的特异性作用,产生荧光光谱的改变。当DNA的二级结构为其他结构时,则不会产生明显的信号变化。以其中化合物6a为例来说明本发明的荧光探针在荧光法(包括荧光显微镜和荧光凝胶成像仪)检测水溶液中、凝胶中和细胞中G-四链体核酸二级结构的应用。The technical solutions of the present invention are further described below through specific examples. It is proved by fluorescence spectrum experiments that the compound 6a involved in the present invention has a large electron conjugation system and plane, and after specific stacking with the G-quadruplex structure, the fluorescence spectrum changes significantly, and the fluorescence intensity increases by a hundred times. Even under the irradiation of ordinary ultraviolet light, it can be observed with the naked eye. At the same time, the interaction with nucleic acids of other secondary structures is weak, and there is no obvious fluorescence signal response, so that this type of probe has a good specific recognition effect. Therefore, when we mix the probe with DNA with different secondary structures, when the DNA is in a G-quadruplex structure, the specific interaction between it and the probe molecule results in a change in the fluorescence spectrum. When the secondary structure of DNA is other structures, there will be no obvious signal changes. Taking compound 6a as an example to illustrate the application of the fluorescent probe of the present invention in detecting the secondary structure of G-quadruplex nucleic acid in aqueous solution, gel and cell by fluorescence method (including fluorescence microscope and fluorescent gel imager).
实施例一:化合物2的合成Example 1: Synthesis of Compound 2
往25ml圆底烧瓶里称取4-氯-喹哪啶0.2g(1.1236mmol),加入碘甲烷,溶剂环丁砜,将混合物加热到40~60℃,反应18个小时后,冷却,加入无水乙醚后震荡,抽滤,固体洗涤数遍,真空干燥后称重,薄层色谱法初步表明没有副产物,得到0.345g纯品2,产率为95.8%:1H NMR(400MHz,DMSO)δ8.56(d,J=8.4Hz,1H),8.46(d,J=8.3Hz,1H),8.22(t,J=8.1Hz,1H),8.01(t,J=7.9Hz,1H),7.55(s,J=7.4Hz,1H),4.20(s,3H),3.74(s,1H),2.68(s,3H).Weigh 0.2 g (1.1236 mmol) of 4-chloro-quinalidine into a 25 ml round-bottomed flask, add methyl iodide and solvent sulfolane, heat the mixture to 40-60 ° C, react for 18 hours, cool, add anhydrous ether After shaking, suction filtration, the solid was washed several times, dried in vacuo, and weighed. Thin-layer chromatography initially showed that there were no by-products, and 0.345 g of pure product 2 was obtained with a yield of 95.8%: 1 H NMR (400 MHz, DMSO) δ8. 56(d, J=8.4Hz, 1H), 8.46(d, J=8.3Hz, 1H), 8.22(t, J=8.1Hz, 1H), 8.01(t, J=7.9Hz, 1H), 7.55( s, J=7.4Hz, 1H), 4.20 (s, 3H), 3.74 (s, 1H), 2.68 (s, 3H).
实施例二:化合物4的合成Example 2: Synthesis of Compound 4
往25ml的圆底烧瓶里称取2-甲基-苯并噻唑0.25g(1.68mmol),加入碘甲烷、溶剂无水乙醇,80℃下反应15个小时后,将反应后的溶液冷却至室温,然后加入无水乙醇和三氯甲烷混合液,振荡后抽滤,并用少量试剂洗涤沉淀,真空干燥后得到白色粉末状固体0.448g,收率为91.7%:1H NMR(400MHz,DMSO)δ8.44(d,J=8.1Hz,1H),8.30(d,J=8.4Hz,1H),7.90(t,J=7.8Hz,1H),7.81(t,J=7.7Hz,1H),4.20(s,3H),3.54(s,1H),3.17(s,3H)。Weigh 0.25g (1.68mmol) of 2-methyl-benzothiazole into a 25ml round-bottomed flask, add methyl iodide and solvent dehydrated ethanol, react at 80°C for 15 hours, and cool the reacted solution to room temperature , and then add a mixture of absolute ethanol and chloroform, oscillate and filter with suction, and wash the precipitate with a small amount of reagents. After vacuum drying, 0.448 g of a white powdery solid is obtained with a yield of 91.7%: 1 H NMR (400 MHz, DMSO) δ8 .44 (d, J=8.1Hz, 1H), 8.30 (d, J=8.4Hz, 1H), 7.90 (t, J=7.8Hz, 1H), 7.81 (t, J=7.7Hz, 1H), 4.20 (s, 3H), 3.54 (s, 1H), 3.17 (s, 3H).
实施例三:化合物5的合成Example 3: Synthesis of Compound 5
称取化合物2和3各0.50g,加入到装有10ml甲醇的圆底烧瓶中,室温条件下搅拌后加入少量0.5mol/L碳酸氢钠水溶液,敞开搅拌约1小时。向反应后的溶液中加入4ml饱和KI溶液,搅拌约5分钟后抽滤,再用水洗,丙酮洗,最终得到砖红色固体,干燥过滤并浓缩后柱层析纯化,得0.98g化合物4,产率为81.7%:1H NMR(400MHz,DMSO)δ8.77(d,J=8.3Hz,1H),8.18(d,J=8.7Hz,1H),8.02-7.96(m,2H),7.74(d,J=8.2Hz,2H),7.59(t,J=7.7Hz,1H),7.39(t,J=7.5Hz,1H),7.34(s,1H),6.85(s,1H),4.07(s,3H),3.98(s,3H),2.87(s,3H)。Weigh 0.50 g of each of compounds 2 and 3 into a round-bottomed flask containing 10 ml of methanol, stir at room temperature, add a small amount of 0.5 mol/L aqueous sodium bicarbonate solution, and stir openly for about 1 hour. 4 ml of saturated KI solution was added to the reacted solution, stirred for about 5 minutes, filtered with suction, washed with water, and washed with acetone to finally obtain a brick-red solid, which was dried, filtered, concentrated, and purified by column chromatography to obtain 0.98 g of compound 4. Rate 81.7%: 1 H NMR (400 MHz, DMSO) δ 8.77 (d, J=8.3 Hz, 1H), 8.18 (d, J=8.7 Hz, 1H), 8.02-7.96 (m, 2H), 7.74 ( d, J=8.2Hz, 2H), 7.59(t, J=7.7Hz, 1H), 7.39(t, J=7.5Hz, 1H), 7.34(s, 1H), 6.85(s, 1H), 4.07( s, 3H), 3.98 (s, 3H), 2.87 (s, 3H).
实施例四:化合物6a的合成Example 4: Synthesis of Compound 6a
称取0.0756g(0.170mmol)的M3于25ml的圆底烧瓶中,加入2倍摩尔量的4,4-二甲基氨基-苯甲醛0.0505g、溶剂正丁醇、4-甲基哌啶数滴,在120~150℃下反应3个小时,冷却后抽滤,用正丁醇和冰水配置的混合溶液洗涤固体,真空干燥称重后得72mg,产率73.4%:1H NMR(400MHz,DMSO)δ8.70(d,J=8.3Hz,1H),8.13(d,J=8.8Hz,1H),8.03(d,J=7.7Hz,1H),7.97-7.92(m,1H),7.79(d,J=8.9Hz,2H),7.71(d,J=7.8Hz,1H),7.69-7.64(m,2H),7.63(s,1H),7.56(t,J=7.8Hz,1H),7.43(d,J=15.7Hz,1H),7.36(t,J=7.6Hz,1H),6.79(d,J=9.1Hz,3H),4.13(s,3H),3.94(s,3H),3.05(s,6H)。Weigh 0.0756g ( 0.170mmol ) of M3 in a 25ml round-bottomed flask, add 2 times the molar amount of 4,4-dimethylamino-benzaldehyde 0.0505g, solvent n-butanol, 4-methylpiperidine A few drops, reacted at 120-150°C for 3 hours, filtered with suction after cooling, washed the solid with a mixed solution of n-butanol and ice water, dried under vacuum and weighed to obtain 72 mg, yield 73.4%: 1 H NMR (400MHz) , DMSO)δ8.70(d, J=8.3Hz, 1H), 8.13(d, J=8.8Hz, 1H), 8.03(d, J=7.7Hz, 1H), 7.97-7.92(m, 1H), 7.79(d, J=8.9Hz, 2H), 7.71(d, J=7.8Hz, 1H), 7.69-7.64(m, 2H), 7.63(s, 1H), 7.56(t, J=7.8Hz, 1H) ), 7.43(d, J=15.7Hz, 1H), 7.36(t, J=7.6Hz, 1H), 6.79(d, J=9.1Hz, 3H), 4.13(s, 3H), 3.94(s, 3H ), 3.05 (s, 6H).
实施例五:化合物6b的合成Example 5: Synthesis of Compound 6b
合成方法同6a,得70mg黑色固体6b,产率76.5%:1H NMR:(400MHz,DMSO-d6)δ12.00(s,1H),8.72(d,J=8.0HZ,1H),8.18(d,J=16.0HZ,3H),8.00(m,3H),7.69(m,3H),7.58(d,J=8.0HZ,2H),7.47(d,J=12.0HZ,1H),7.35(t,J=8.0HZ,1H),7.27(s,2H),6.82(s,1H),4.19(s,3H),4.94(s,3H)。The synthesis method was the same as that of 6a, and 70 mg of black solid 6b was obtained with a yield of 76.5%: 1 H NMR: (400 MHz, DMSO-d 6 )δ12.00(s, 1H), 8.72(d, J=8.0H Z , 1H), 8.18(d, J=16.0H Z , 3H), 8.00(m, 3H), 7.69(m, 3H), 7.58(d, J=8.0H Z , 2H), 7.47(d, J=12.0H Z , 1H), 7.35 (t, J= 8.0HZ , 1H), 7.27 (s, 2H), 6.82 (s, 1H), 4.19 (s, 3H), 4.94 (s, 3H).
实施例六:化合物6c的合成Example 6: Synthesis of compound 6c
合成方法同6a,得79mg紫色固体6c,产率83.5%:1H NMR(400MHz,DMSO)δ8.70(d,J=8.5Hz,1H),8.12(d,J=8.9Hz,1H),8.07(d,J=7.9Hz,1H),7.95(t,J=7.8Hz,1H),7.73-7.68(m,2H),7.59(dd,J=13.5,7.0Hz,3H),7.49(d,J=8.7Hz,2H),7.39(t,J=7.6Hz,1H),7.17(dd,J=24.7,13.8Hz,3H),6.83-6.76(m,3H),4.09(d,J=8.5Hz,3H),3.96(s,3H),3.00(d,J=11.7Hz,6H)The synthesis method was the same as that of 6a, and 79 mg of purple solid 6c was obtained with a yield of 83.5%: 1 H NMR (400 MHz, DMSO) δ 8.70 (d, J=8.5 Hz, 1H), 8.12 (d, J=8.9 Hz, 1H), 8.07(d, J=7.9Hz, 1H), 7.95(t, J=7.8Hz, 1H), 7.73-7.68(m, 2H), 7.59(dd, J=13.5, 7.0Hz, 3H), 7.49(d , J=8.7Hz, 2H), 7.39 (t, J=7.6Hz, 1H), 7.17 (dd, J=24.7, 13.8Hz, 3H), 6.83-6.76 (m, 3H), 4.09 (d, J= 8.5Hz, 3H), 3.96(s, 3H), 3.00(d, J=11.7Hz, 6H)
实施例七:化合物6d的合成Example 7: Synthesis of compound 6d
合成方法同6a,得76mg红色固体6d,产率77.4%:1H NMR(400MHz,DMSO)δ8.69(d,J=8.4Hz,1H),8.01(ddd,J=13.8,10.1,7.4Hz,4H),7.94-7.89(m,1H),7.69(t,J=7.4Hz,1H),7.64(d,J=4.5Hz,1H),7.60(d,J=9.5Hz,1H),7.58-7.49(m,2H),7.44(s,1H),7.34(dd,J=19.2,8.3Hz,3H),6.79(s,1H),4.07(s,3H),3.92(s,3H).The synthesis method was the same as that of 6a, and 76 mg of red solid 6d was obtained with a yield of 77.4%: 1 H NMR (400 MHz, DMSO) δ 8.69 (d, J=8.4 Hz, 1H), 8.01 (ddd, J=13.8, 10.1, 7.4 Hz) , 4H), 7.94-7.89 (m, 1H), 7.69 (t, J=7.4Hz, 1H), 7.64 (d, J=4.5Hz, 1H), 7.60 (d, J=9.5Hz, 1H), 7.58 -7.49(m, 2H), 7.44(s, 1H), 7.34(dd, J=19.2, 8.3Hz, 3H), 6.79(s, 1H), 4.07(s, 3H), 3.92(s, 3H).
实施例八:化合物6e的合成Example 8: Synthesis of compound 6e
合成方法同6a,得82mg褐色固体6e,产率85.6%:1H NMR(400MHz,DMSO)δ9.10(s,1H),8.77(s,1H),8.66(d,J=3.7Hz,1H),8.39(d,J=7.3Hz,1H),8.17(s,1H),8.06(d,J=7.5Hz,1H),7.99(s,1H),7.91(d,J=15.9Hz,1H),7.74(s,2H),7.67(d,J=18.3Hz,1H),7.65-7.52(m,3H),7.41(s,1H),6.91(s,1H),4.16(s,3H),4.00(s,3H).The synthesis method was the same as that of 6a, and 82 mg of brown solid 6e was obtained in 85.6% yield: 1 H NMR (400 MHz, DMSO) δ 9.10 (s, 1H), 8.77 (s, 1H), 8.66 (d, J=3.7 Hz, 1H) ), 8.39(d, J=7.3Hz, 1H), 8.17(s, 1H), 8.06(d, J=7.5Hz, 1H), 7.99(s, 1H), 7.91(d, J=15.9Hz, 1H) ), 7.74(s, 2H), 7.67(d, J=18.3Hz, 1H), 7.65-7.52(m, 3H), 7.41(s, 1H), 6.91(s, 1H), 4.16(s, 3H) , 4.00(s, 3H).
实施例九:化合物6f的合成Example 9: Synthesis of compound 6f
合成方法同6a,得80mg紫黑色固体6e,产率83.2%:1H NMR(400MHz,DMSO)δ8.73(t,J=10.7Hz,1H),8.10(dd,J=18.2,9.6Hz,2H),7.97-7.92(m,1H),7.74-7.68(m,2H),7.67-7.61(m,2H),7.60-7.51(m,3H),7.45(dd,J=13.6,5.9Hz,2H),7.42-7.35(m,3H),7.31(d,J=15.2Hz,2H),6.83(d,J=9.2Hz,1H),4.06(d,J=14.2Hz,3H),3.97(d,J=7.1Hz,3H).The synthesis method was the same as that of 6a, and 80 mg of purple-black solid 6e was obtained in 83.2% yield: 1 H NMR (400 MHz, DMSO) δ 8.73 (t, J=10.7 Hz, 1H), 8.10 (dd, J=18.2, 9.6 Hz, 2H), 7.97-7.92 (m, 1H), 7.74-7.68 (m, 2H), 7.67-7.61 (m, 2H), 7.60-7.51 (m, 3H), 7.45 (dd, J=13.6, 5.9Hz, 2H), 7.42-7.35 (m, 3H), 7.31 (d, J=15.2Hz, 2H), 6.83 (d, J=9.2Hz, 1H), 4.06 (d, J=14.2Hz, 3H), 3.97 ( d, J=7.1Hz, 3H).
实施例十:核酸选择性Example 10: Nucleic acid selectivity
DNA配置:DNA样品购自英骏生物技术有限公司。将DNA适量溶于Tris-HCl的缓冲液中(PH 7.4,100mM Tris,60mM KCl)或者Tris-醋酸缓冲中(PH 5.5,100mM Tris,60mMKCl),超微量紫外定浓,在95℃下加热5min后缓慢冷却退火到室温作为储存液,4℃储存。DNA configuration: DNA samples were purchased from Yingjun Biotechnology Co., Ltd. Dissolve an appropriate amount of DNA in Tris-HCl buffer (pH 7.4, 100mM Tris, 60mM KCl) or Tris-acetate buffer (pH 5.5, 100mM Tris, 60mM KCl), and heat at 95°C for 5min. After slow cooling and annealing to room temperature as a storage solution, stored at 4 °C.
将5mM的化合物储备液稀释成5uM的浓度,再加入不同种类的核酸用荧光分光光度计(狭缝宽度=10,扫描速度=200,Ex=475nm)测出其各自的荧光强度,发现这一系类化合物与G-四链体DNA的结合之后荧光强度最强.The 5mM compound stock solution was diluted to a concentration of 5uM, and then different kinds of nucleic acids were added to measure their respective fluorescence intensities with a spectrofluorometer (slit width = 10, scan speed = 200, Ex = 475 nm), and found this. The fluorescence intensity was the strongest after the combination of these compounds with G-quadruplex DNA.
DNA序列DNA sequence
实施例十一:检测限的测定Example 11: Determination of detection limit
将5mM的化合物储备液稀释成5uM的浓度,再在荧光分光光度计(狭缝宽度=10,扫描速度=200,Ex=475nm)扫描,再往其中慢慢加入Oxy28的DNA做到使其饱和.检测限的计算公式Dilute the 5mM compound stock solution to a concentration of 5uM, then scan in a spectrofluorometer (slit width=10, scan speed=200, Ex=475nm), and then slowly add Oxy28 DNA to it to saturate it .Calculation formula of detection limit
LOD=K×Sb/mLOD=K×S b /m
LOD(化合物的检测限),m是浓度C与(F-F0)/F0的所做直线的斜率,Sb为用仪器空白多次测量的标准偏差,K值按照国际纯粹和应用化学联合会建议通常取为3,6a测得的LOD为0.87nM.LOD (limit of detection for a compound), m is the slope of the straight line drawn between concentration C and (FF 0 )/F 0 , S b is the standard deviation of multiple measurements with instrument blanks, and K values are according to the International Union of Pure and Applied Chemistry It is recommended to usually take 3, and the measured LOD of 6a is 0.87nM.
实施例十二:核酸凝胶电泳实验Example 12: Nucleic acid gel electrophoresis experiment
先将5×TBE电泳缓冲液、过硫酸铵10%m/V、6X载样缓冲液、亚甲双丙酰胺(29∶1)(%,m/V)配好,接着安装电泳装置和配置凝胶溶液,灌制凝胶,待凝胶冷却之后取出梳子和隔板,放入电泳槽中,缓冲液淹没过胶1-2mm为止,DNA样品配成5μM(混合液中上样缓冲液为1×),取10μL加入凝胶点样孔中,将整个电泳仪接通,45V电压跑1h,接着100V电压跑3h,取出凝胶块,再将凝胶块放入染色剂和化合物中泡染,染过之后吹干,将其置于凝胶电泳仪上观察.First prepare 5×TBE running buffer, ammonium persulfate 10% m/V, 6X loading buffer, methylenebispropionamide (29:1) (%, m/V), then install the electrophoresis device and configure Gel solution, pour the gel, take out the comb and the separator after the gel is cooled, put it into the electrophoresis tank, the buffer submerges the gel for 1-2mm, and the DNA sample is made into 5μM (the loading buffer in the mixture is 1 ×), add 10 μL to the gel spotting well, turn on the entire electrophoresis apparatus, run at 45V for 1 hour, then run at 100V for 3 hours, take out the gel block, and then put the gel block into the dye and compound to soak in the dye. , dried after dyeing, and placed on a gel electrophoresis apparatus for observation.
实施例十三:细胞成像实验Example Thirteen: Cell Imaging Experiment
先将细胞接种于6孔板中,使细胞的密度约为2×103个/mL,然后在37℃、5%CO2环境中培养24h。接着弃去上步6孔板中的细胞培养液,用预冷的1×PBS洗3次,然后再加入预冷的纯甲醇1.5mL常温避光放置1min,最后弃去纯甲醇并再用预冷的1×PBS洗3次,加入1mL的5μM的化合物然后放置15min。弃去上步6孔板中的化合物溶液,用预冷的1×PBS洗3次,在上述6孔板中加入1μM的DAPI溶液1mL并37℃放置2min,然后再用预冷的1×PBS洗6次,每次浸泡5min。在倒置荧光显微镜下观察细胞染色情况。The cells were first seeded in a 6-well plate so that the density of the cells was about 2×10 3 cells/mL, and then cultured at 37° C. and 5% CO 2 for 24 h. Then discard the cell culture medium in the 6-well plate in the previous step, wash 3 times with pre-cooled 1×PBS, then add 1.5 mL of pre-cooled pure methanol and place in the dark at room temperature for 1 min. Finally, discard the pure methanol and use pre-cooled pure methanol again. Washed 3 times with cold 1×PBS, added 1 mL of 5 μM compound and left for 15 min. Discard the compound solution in the 6-well plate in the previous step, wash 3 times with pre-cooled 1×PBS, add 1 mL of 1 μM DAPI solution to the above 6-well plate and place it at 37°C for 2min, and then use pre-cooled 1×PBS. Wash 6 times, soak for 5min each time. Cell staining was observed under an inverted fluorescence microscope.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510213543.6A CN106147753B (en) | 2015-04-24 | 2015-04-24 | Thiazole orange styrene compound as G-quadruplex nucleic acid fluorescent probe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510213543.6A CN106147753B (en) | 2015-04-24 | 2015-04-24 | Thiazole orange styrene compound as G-quadruplex nucleic acid fluorescent probe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106147753A CN106147753A (en) | 2016-11-23 |
CN106147753B true CN106147753B (en) | 2020-03-10 |
Family
ID=57347509
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510213543.6A Active CN106147753B (en) | 2015-04-24 | 2015-04-24 | Thiazole orange styrene compound as G-quadruplex nucleic acid fluorescent probe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106147753B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106188031B (en) * | 2016-06-30 | 2019-11-26 | 广东工业大学 | Thiazole orange styrene derivative and preparation method thereof and preparing the application in drug-resistance bacteria medicine |
CN106749208B (en) * | 2016-11-25 | 2019-10-01 | 中山大学 | A kind of polyaryl substituted imidazole fluorescence probe and preparation method thereof and the application in tetra- serobila of specific detection G- |
CN108558853B (en) * | 2018-01-15 | 2020-09-11 | 广东工业大学 | A compound and its preparation method and application |
CN108165045B (en) * | 2018-01-15 | 2021-03-16 | 广东工业大学 | Nucleic acid dye compound and preparation method and application thereof |
CN110483394A (en) * | 2019-09-02 | 2019-11-22 | 广东工业大学 | A kind of application of compound |
CN110606862B (en) * | 2019-10-24 | 2021-02-26 | 浙江大学 | Platinum complex fluorescent probe for specifically detecting RNA G-quadruplex, preparation method and application |
CN111233856A (en) * | 2020-02-17 | 2020-06-05 | 广州市尚信净化工程有限公司 | Preparation method of fluorescent probe test paper for detecting chromium content in soil |
CN111303143A (en) * | 2020-02-17 | 2020-06-19 | 广州市尚信净化工程有限公司 | Preparation method of fluorescent probe test paper for detecting cadmium content in soil |
CN111961042B (en) * | 2020-07-23 | 2022-08-12 | 中国科学院化学研究所 | Compound and detection method for detecting abnormal amplification of GGCCTG repeat sequence of ridge SCA36 gene |
CN112079827B (en) * | 2020-08-19 | 2023-02-10 | 广东工业大学 | Thiazole orange derivative, preparation method thereof and application thereof in mitochondria |
CN113583467B (en) * | 2021-08-20 | 2022-04-26 | 四川大学 | A nucleic acid fluorescent dye and its preparation and application |
CN114716431B (en) * | 2022-02-17 | 2022-11-11 | 北京富百科生物技术有限公司 | Synthesis and application of phenanthridine and benzothiazole conjugated linked fluorescent dye |
CN116143770B (en) * | 2022-12-02 | 2024-09-20 | 广东工业大学 | Quinoline derivative and preparation method and application thereof |
CN116375626B (en) * | 2023-03-16 | 2025-04-08 | 安徽大学 | A fluorescent probe for identifying G-quadruplex DNA and a preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863753A (en) * | 1994-10-27 | 1999-01-26 | Molecular Probes, Inc. | Chemically reactive unsymmetrical cyanine dyes and their conjugates |
CN103788940A (en) * | 2012-11-02 | 2014-05-14 | 国家纳米科学中心 | Aggregation-induced emission fluorescent molecule as well as preparation method and fluorescent dye composition, and application of aggregation-induced emission fluorescent molecule and fluorescent dye composition in mitochondria dyeing |
CN104650609A (en) * | 2013-11-22 | 2015-05-27 | 沈阳药科大学 | Thiazol orange derivative, manufacturing method and application of thiazol orange derivative used as double helix nucleic acid fluorescence molecular probe |
-
2015
- 2015-04-24 CN CN201510213543.6A patent/CN106147753B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5863753A (en) * | 1994-10-27 | 1999-01-26 | Molecular Probes, Inc. | Chemically reactive unsymmetrical cyanine dyes and their conjugates |
CN103788940A (en) * | 2012-11-02 | 2014-05-14 | 国家纳米科学中心 | Aggregation-induced emission fluorescent molecule as well as preparation method and fluorescent dye composition, and application of aggregation-induced emission fluorescent molecule and fluorescent dye composition in mitochondria dyeing |
CN104650609A (en) * | 2013-11-22 | 2015-05-27 | 沈阳药科大学 | Thiazol orange derivative, manufacturing method and application of thiazol orange derivative used as double helix nucleic acid fluorescence molecular probe |
Also Published As
Publication number | Publication date |
---|---|
CN106147753A (en) | 2016-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106147753B (en) | Thiazole orange styrene compound as G-quadruplex nucleic acid fluorescent probe | |
CN106833623B (en) | A kind of fluorescent probe and preparation method thereof | |
CN106147752B (en) | RNA fluorescent probe and preparation method and application thereof | |
JP7227741B2 (en) | Carboxy X rhodamine analog | |
CN102719238B (en) | Dual-functional probe and preparation method and application in detection of G-quadruplex structure thereof | |
CN104449669B (en) | A kind of polyaryl substituted imidazole fluorescence probe and preparation method thereof and the application in detection G-tetra-stranded structure | |
CN108752331A (en) | Synthesis and application a kind of while that distinguish detection Cys, Hcy and GSH Multifunction fluorescent molecular probe | |
CN108069967B (en) | Fluorescent probe for intracellular protein labeling and synthetic method and application thereof | |
CN107266417A (en) | A kind of indoles ethene substd quinolines analog derivative and its preparation method and application | |
CN108329302A (en) | A kind of half flower cyanines class near infrared fluorescent probe compound of sulfide specificly-response and its preparation method and application | |
CN107311977B (en) | Indole ethylene compound and preparation method and application thereof | |
Zheng et al. | Rational design of Red fluorescent and selective G-quadruplex DNA sensing probes: The study of interaction signaling and the molecular structural relationship achieving high specificity | |
CN112174885B (en) | P-dimethylamino styrene quinoline derivative, synthetic method thereof and application thereof in nucleic acid fluorescent probe | |
Hu | Pyrazine-based G-quadruplex fluorescent probes: Transformation between aggregation-induced emission and disaggregation-induced emission via slight variations in structures | |
CN104710977B (en) | A kind of double function probe and preparation method thereof and the application in detecting positive parallel conformation G-tetra-serobila | |
CN104151325B (en) | Fluorescent probe with rhodamine fluorophore as matrix and preparation method of fluorescent probe with rhodamine fluorophore as matrix | |
CN108558853B (en) | A compound and its preparation method and application | |
CN113200988B (en) | Synthesis and application of bifunctional fluorescent probe for simultaneously detecting hydroxyl free radicals and viscosity | |
CN110627715B (en) | Quinoline aromatic ethylene derivative and application thereof in preparation of fluorescent dye and fluorescent probe | |
CN106543251A (en) | Nitric oxide production water-soluble fluorescent probe and its application in a kind of detection hepatocyte | |
CN111892588B (en) | A kind of indole-benzothiazole derivative and its preparation method and application | |
CN102408741B (en) | A kind of dye and its preparation method and its application in detecting special DNA secondary structure | |
CN107586292A (en) | Compound, its preparation method, fluorescent dye and fluorescence probe | |
CN108264502B (en) | Quinoline carbazole fluorescent dye and its preparation method and application | |
CN113121541B (en) | Synthesis and application of a fluorescent probe for simultaneously distinguishing between gold ions Au3+ and palladium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |